Louis W. Sullivan, Director at UNITED THERAPEUTICS Corp (UTHR), sold 11,120 shares at $226.74 ($2.5M) on 2022-05-26, disclosed to the SEC on 2022-05-26.
Open-market sale of $2.5M UTHR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $223.37 | 1,699 | $380K | 15.2% |
| 2 | $223.37 | 1,699 | $380K | 15.2% |
| 3 | $224.38 | 1,766 | $396K | 15.8% |
| 4 | $224.38 | 1,766 | $396K | 15.8% |
| 5 | $226.04 | 1,500 | $339K | 13.6% |
| 6 | $226.74 | 1,345 |
| $305K |
| 12.2% |
| 7 | $226.74 | 1,345 | $305K | 12.2% |
| Total | $224.87 avg | 11,120 | $2.5M | 100% |
| Filing → |
| UTHR | SELL | 2024-05-06 | $2.7M | — | Filing → |
| UTHR | SELL | 2023-03-02 | $172K | — | Filing → |
| UTHR | SELL | 2023-02-02 | $183K | — | Filing → |